The Convergent Procedure: A Unique Multidisciplinary Hybrid Treatment of Atrial Fibrillation

J Cardiothorac Vasc Anesth. 2021 Feb;35(2):631-643. doi: 10.1053/j.jvca.2020.07.034. Epub 2020 Jul 16.

Abstract

The convergent procedure is a hybrid ablation treatment for atrial fibrillation. It is increasingly considered as a management option for patients with persistent and long-standing atrial fibrillation. It consists of surgical ablation of the posterior left atrium through a minimally invasive closed-chest approach followed by endocardial catheter ablation. It is increasingly performed with concurrent epicardial occlusion of the left atrial appendage with a video-assisted thoracoscopic technique to physically and electrically isolate the left atrial appendage. This article provides an overview of a multidisciplinary approach to the convergent procedure, with concurrent thoracoscopic closure of the left atrial appendage, with an emphasis on perioperative management at a single institution. It provides a literature review of procedural outcomes, current data limitations, and future considerations.

Keywords: Atrial fibrillation; ablation; arrhythmia therapy; convergent; epicardial-endocardial ablation; hybrid ablation.

Publication types

  • Review

MeSH terms

  • Atrial Fibrillation* / surgery
  • Catheter Ablation*
  • Humans
  • Recurrence
  • Time Factors
  • Treatment Outcome